Millennium Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Millennium Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,901	Closed	-$291K	–	3577
2015 Q3	$291K	Sell	5,901 -2,055	-26%	-$118K	﹤0.01%	2927
2015 Q2	$464K	Sell	7,956 -3,195	-29%	-$187K	﹤0.01%	2669
2015 Q1	$641K	Buy	+11,151	New	+$610K	﹤0.01%	2599

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's IHE Position: Q4 2015 in Review

Millennium Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 5,901 shares — an estimated $291K sold.

Millennium Management first reported a position in IHE in Q1 2015 and held it in 3 quarters. The position peaked at $641K in Q1 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

Millennium Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Millennium Management sold 5,901 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $291K.
Millennium Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 3 quarters.
Millennium Management's iShares US Pharmaceuticals ETF position peaked at $641K in Q1 2015.
103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.